Hyaluronate and Derivatives and Inotuzumab ozogamicin
Determining the interaction of Hyaluronate and Derivatives and Inotuzumab ozogamicin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronan
Brand name: Hymovis, Monovisc, Orthovisc, Hydase
Synonyms: Hyaluronan
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab Ozogamicin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyaluronate and Derivatives-Inotuzumab ozogamicin Intravenous
- Hyaluronate and Derivatives-Inova
- Hyaluronate and Derivatives-Inova 4/1 topical
- Hyaluronate and Derivatives-Inova 8/2 topical
- Hyaluronate and Derivatives-Inova ACT
- Hyaluronate and Derivatives-Inrebic
- Inotuzumab ozogamicin-Hyaluronate and Derivatives Injection (Knee)
- Inotuzumab ozogamicin-Hyaluronate sodium Injection
- Inotuzumab ozogamicin-Hyaluronidase
- Inotuzumab ozogamicin-Hyaluronidase and immune globulin
- Inotuzumab ozogamicin-Hyaluronidase and rituximab
- Inotuzumab ozogamicin-Hyaluronidase and trastuzumab